Texas Oncology - Longview Cancer Center is a clinical research site located in Longview, Texas, United States 75601.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
Texas Oncology - Longview Cancer Center has participated in 9 clinical trials with 1 currently active.
Therapeutic areas: Advanced, Androgen Receptor Positive Triple Negative Breast Cancer, Follicular Lymphoma, Solid Tumor.
Sponsors: Pfizer, Tempus AI, G1 Therapeutics, Inc..
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Texas Oncology - Longview Cancer Center has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Texas Oncology - Longview Cancer Center has 9 clinical trials on record, with 1 currently active. Their work covers Advanced, Androgen Receptor Positive Triple Negative Breast Cancer, Follicular Lymphoma, Solid Tumor.
Yes — Texas Oncology - Longview Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.